Lanean...
An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
BACKGROUND: Recent reports of the remarkable therapeutic efficacy of 225Ac-labeled PSMA-617 for therapy of metastatic castration-resistant prostate cancer have under-lined the clinical potential of targeted alpha therapy. OBJECTIVE AND CONCLUSION: This review describes methods for the production of...
Gorde:
| Argitaratua izan da: | Curr Radiopharm |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Bentham Science Publishers
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237921/ https://ncbi.nlm.nih.gov/pubmed/29732998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874471011666180502104524 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|